Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075495244> ?p ?o ?g. }
- W2075495244 endingPage "262" @default.
- W2075495244 startingPage "258" @default.
- W2075495244 abstract "Background The development of symptomatic strictures in Crohn's Disease after anti-Tumour Necrosis Factor-α antibodies is undefined. Aim To assess, in a prospective longitudinal study, the frequency of sub/obstructions in Crohn's Disease patients after treatment with Infliximab or Adalimumab. Changes of small bowel lesions after these biological therapies were searched by ultrasonography. Materials and Methods From January 2007 to October 2008, 36 Crohn's Disease patients with no previous sub/obstructions were treated with either Infliximab (n = 13) or Adalimumab (n = 23) for ≥12 months (mean follow-up duration after the first treatment 23.2 ± 6.8 months). Small Intestine Contrast Ultrasonography was performed before and after treatment in 19/36 patients. Sonographic parameters included: bowel wall thickness, lumen diameter, bowel dilation and lesion extent. Results Sub/obstructions developed in 3/36 patients treated with Infliximab (n = 1) or Adalimumab (n = 2), all with fibrostricturing Crohn's Disease. Sonographic parameters did not significantly change after treatment. Conclusions Sub/obstructive symptoms may develop in one tenth of Crohn's Disease patients treated with anti-Tumour Necrosis Factor-α antibodies, with no significant sonographic changes of the small bowel lesions." @default.
- W2075495244 created "2016-06-24" @default.
- W2075495244 creator A5009705533 @default.
- W2075495244 creator A5044577178 @default.
- W2075495244 creator A5044820486 @default.
- W2075495244 creator A5059920966 @default.
- W2075495244 creator A5065005318 @default.
- W2075495244 creator A5066481245 @default.
- W2075495244 creator A5068845753 @default.
- W2075495244 creator A5086201689 @default.
- W2075495244 creator A5087405062 @default.
- W2075495244 date "2013-03-01" @default.
- W2075495244 modified "2023-09-23" @default.
- W2075495244 title "Anti-TNF-alpha treatments and obstructive symptoms in Crohn's Disease: A prospective study" @default.
- W2075495244 cites W1971685694 @default.
- W2075495244 cites W1986125265 @default.
- W2075495244 cites W1991810959 @default.
- W2075495244 cites W1997347766 @default.
- W2075495244 cites W2016799664 @default.
- W2075495244 cites W2022150136 @default.
- W2075495244 cites W2028002767 @default.
- W2075495244 cites W2036049422 @default.
- W2075495244 cites W2036202992 @default.
- W2075495244 cites W2037634914 @default.
- W2075495244 cites W2043041351 @default.
- W2075495244 cites W2048729604 @default.
- W2075495244 cites W2052476019 @default.
- W2075495244 cites W2073820088 @default.
- W2075495244 cites W2090015658 @default.
- W2075495244 cites W2090031459 @default.
- W2075495244 cites W2094942596 @default.
- W2075495244 cites W2104512777 @default.
- W2075495244 cites W2104784902 @default.
- W2075495244 cites W2115865518 @default.
- W2075495244 cites W2121609590 @default.
- W2075495244 cites W2127693350 @default.
- W2075495244 cites W2133493191 @default.
- W2075495244 cites W2141802511 @default.
- W2075495244 cites W2144550346 @default.
- W2075495244 cites W2152026434 @default.
- W2075495244 cites W2155125073 @default.
- W2075495244 cites W2160280827 @default.
- W2075495244 cites W2163027666 @default.
- W2075495244 cites W2167806388 @default.
- W2075495244 cites W2171341132 @default.
- W2075495244 cites W2182311867 @default.
- W2075495244 cites W2321453230 @default.
- W2075495244 cites W2510350041 @default.
- W2075495244 cites W2615184173 @default.
- W2075495244 cites W3149527659 @default.
- W2075495244 cites W4238725981 @default.
- W2075495244 doi "https://doi.org/10.1016/j.dld.2012.10.009" @default.
- W2075495244 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23195667" @default.
- W2075495244 hasPublicationYear "2013" @default.
- W2075495244 type Work @default.
- W2075495244 sameAs 2075495244 @default.
- W2075495244 citedByCount "37" @default.
- W2075495244 countsByYear W20754952442012 @default.
- W2075495244 countsByYear W20754952442014 @default.
- W2075495244 countsByYear W20754952442015 @default.
- W2075495244 countsByYear W20754952442016 @default.
- W2075495244 countsByYear W20754952442017 @default.
- W2075495244 countsByYear W20754952442018 @default.
- W2075495244 countsByYear W20754952442019 @default.
- W2075495244 countsByYear W20754952442020 @default.
- W2075495244 countsByYear W20754952442021 @default.
- W2075495244 countsByYear W20754952442022 @default.
- W2075495244 countsByYear W20754952442023 @default.
- W2075495244 crossrefType "journal-article" @default.
- W2075495244 hasAuthorship W2075495244A5009705533 @default.
- W2075495244 hasAuthorship W2075495244A5044577178 @default.
- W2075495244 hasAuthorship W2075495244A5044820486 @default.
- W2075495244 hasAuthorship W2075495244A5059920966 @default.
- W2075495244 hasAuthorship W2075495244A5065005318 @default.
- W2075495244 hasAuthorship W2075495244A5066481245 @default.
- W2075495244 hasAuthorship W2075495244A5068845753 @default.
- W2075495244 hasAuthorship W2075495244A5086201689 @default.
- W2075495244 hasAuthorship W2075495244A5087405062 @default.
- W2075495244 hasConcept C126322002 @default.
- W2075495244 hasConcept C141071460 @default.
- W2075495244 hasConcept C188816634 @default.
- W2075495244 hasConcept C2777138892 @default.
- W2075495244 hasConcept C2778260677 @default.
- W2075495244 hasConcept C2779134260 @default.
- W2075495244 hasConcept C2779280984 @default.
- W2075495244 hasConcept C2780132546 @default.
- W2075495244 hasConcept C2781156865 @default.
- W2075495244 hasConcept C71924100 @default.
- W2075495244 hasConcept C90924648 @default.
- W2075495244 hasConceptScore W2075495244C126322002 @default.
- W2075495244 hasConceptScore W2075495244C141071460 @default.
- W2075495244 hasConceptScore W2075495244C188816634 @default.
- W2075495244 hasConceptScore W2075495244C2777138892 @default.
- W2075495244 hasConceptScore W2075495244C2778260677 @default.
- W2075495244 hasConceptScore W2075495244C2779134260 @default.
- W2075495244 hasConceptScore W2075495244C2779280984 @default.
- W2075495244 hasConceptScore W2075495244C2780132546 @default.
- W2075495244 hasConceptScore W2075495244C2781156865 @default.